About Precept Pharma Limited
Data last updated:
Precept Pharma Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24239CH2006PLC030622. Its GSTIN is 02AAECP3168P1Z5 (Himachal Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Ishwar Datta Sharma and Anil Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at #269 Sector 15 – A, Chandigarh, India – 160016.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.38 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.23 Cr (net margin 22.4%) and EBITDA of ₹7.69 Cr (EBITDA margin 32.9%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 18% over five years.
The company is associated with 1 brand: Precept Pharma Ltd. As per MCA filings, the company has satisfied charges of ₹1.34 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website preceptpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address#269 Sector 15 – A, Chandigarh, India – 160016
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Precept Pharma Limited
The main business activities of Precept Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Precept Pharma Limited FY 2024 filings available
Precept Pharma Limited reported revenue of ₹23.38 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Precept Pharma Limited
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Precept Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹7.69 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.23 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Precept Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 22.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Precept Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Precept Pharma Limited
Precept Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sayre Therapeutics Private Limited | ₹23.68 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Somasundara Palya, Karnataka, India |
| Dueful Healthcare Private Limited | ₹23.56 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Jaipur, Rajasthan, India |
| Auro Peptides Limited | ₹23.52 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Hyderabad, Telangana, India |
| Medisol Lifescience Private Limited | ₹23.51 Cr (FY 2024) | •••• | •••• | 158.0% | •••• | Mumbai, Maharashtra, India |
| Bini Laboratories Private Limited | ₹23.43 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Precept Pharma Limited this company | ₹23.38 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Chandigarh, India |
| Alvista Biosciences Private Limited | ₹23.38 Cr (FY 2025) | •••• | •••• | 146.0% | •••• | New Delhi, Delhi, India |
| HPS Laboratories Private Limited | ₹23.36 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Hyderabad, Telangana, India |
| Govind Laboratories Private Limited | ₹23.3 Cr (FY 2024) | •••• | •••• | 92.0% | •••• | Ahnedabad, Gujarat, India |
| Health Line Pharmaceuticals Private Limited | ₹23.25 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Go-Ish Remedies Limited | ₹23.23 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Nalagarh, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Precept Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Precept Pharma Limited
Precept Pharma Limited is audited by AJAY PATHAK & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AJAY PATHAK & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Precept Pharma Limited
Precept Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ishwar Datta Sharma | Director | 09 Nov 2006 | 19 Years 11 Months | Current |
| Anil Sharma | Director | 09 Nov 2006 | 19 Years 11 Months | Current |
| Rachna Sharma | Director | 09 Nov 2006 | 19 Years 11 Months | Current |
Ownership and Shareholding of Precept Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Precept Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2020 | Hdfc Bank Limited | ₹99 Lakh | Satisfied |
| 27 Oct 2016 | Hdfc Bank Limited | ₹35 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Precept Pharma Limited
Precept Pharma Limited has 2 court cases on record: 2 filed by Precept Pharma. All cases are disposed. Status as checked between 03 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Court case (CS CJ) | Filed by the company against an individual | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Precept Pharma Limited
Precept Pharma operates one associated brand: Precept Pharma Ltd. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations, R&D, and technical services in India. | preceptpharma.com |
Employees and EPFO Compliance at Precept Pharma Limited
Employment history and EPFO contributions of people linked to Precept Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Precept Pharma Limited
Precept Pharma Limited has 3 board changes on record since 2006: 3 appointments. The latest: Anil Sharma was appointed as Director on 09 Nov 2006.
Credit Ratings, Litigation & Regulatory Alerts for Precept Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Precept Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Precept Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Precept Pharma Limited
Precept Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAECP3168P1Z5 | Himachal Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Precept Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precept Pharma Limited
Precept Pharma is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 2006 (20+ years old) and is registered under CIN U24239CH2006PLC030622.
Precept Pharma reported revenue of ₹23.38 Cr for FY 2025 (down 6% YoY).
Precept Pharma has 3 current directors:
- Ishwar Datta Sharma - Director
- Anil Sharma - Director
- Rachna Sharma - Director
Precept Pharma reported a net profit of ₹5.23 Cr (net margin 22.4%) and EBITDA of ₹7.69 Cr (EBITDA margin 32.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Precept Pharma is 12% over three years and 18% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Precept Pharma is 02AAECP3168P1Z5, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Precept Pharma is U24239CH2006PLC030622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Precept Pharma has 2 court cases on record: 2 filed by the company.
Precept Pharma was incorporated on 09 November 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Precept Pharma by revenue are Sayre Therapeutics Private Limited, Dueful Healthcare Private Limited, Auro Peptides Limited, Medisol Lifescience Private Limited, Bini Laboratories Private Limited and 5 more, all in the Pharma industry (Formulations).
Anil Sharma was appointed as Director on 09 Nov 2006. Ishwar Datta Sharma was appointed as Director on 09 Nov 2006. Rachna Sharma was appointed as Director on 09 Nov 2006.